Your browser is no longer supported. Please, upgrade your browser.
Settings
AERI Aerie Pharmaceuticals, Inc. daily Stock Chart
AERI [NASD]
Aerie Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-3.35 Insider Own2.15% Shs Outstand36.21M Perf Week6.83%
Market Cap2.21B Forward P/E- EPS next Y-2.49 Insider Trans0.00% Shs Float35.92M Perf Month6.55%
Income-115.90M PEG- EPS next Q-1.23 Inst Own- Short Float10.83% Perf Quarter-6.30%
Sales- P/S- EPS this Y-17.90% Inst Trans-0.22% Short Ratio10.83 Perf Half Y5.90%
Book/sh4.40 P/B13.86 EPS next Y22.40% ROA-41.90% Target Price80.00 Perf Year48.60%
Cash/sh7.77 P/C7.85 EPS next 5Y- ROE-86.90% 52W Range38.14 - 66.60 Perf YTD2.09%
Dividend- P/FCF- EPS past 5Y25.20% ROI- 52W High-8.41% Beta0.95
Dividend %- Quick Ratio15.20 Sales past 5Y- Gross Margin- 52W Low59.95% ATR1.89
Employees95 Current Ratio15.20 Sales Q/Q- Oper. Margin- RSI (14)57.08 Volatility3.15% 3.06%
OptionableYes Debt/Eq0.78 EPS Q/Q-10.30% Profit Margin- Rel Volume1.11 Prev Close59.95
ShortableYes LT Debt/Eq0.78 EarningsFeb 07 AMC Payout- Avg Volume359.11K Price61.00
Recom1.80 SMA202.74% SMA501.65% SMA20012.11% Volume397,341 Change1.75%
Oct-24-17Initiated Guggenheim Buy $80
Oct-16-17Reiterated Needham Buy $65 → $76
Jul-20-17Reiterated Cantor Fitzgerald Overweight $56 → $62
May-25-17Reiterated Needham Buy $58 → $65
Mar-09-17Downgrade Raymond James Strong Buy → Mkt Perform
Mar-08-17Reiterated RBC Capital Mkts Outperform $54 → $55
Mar-08-17Reiterated Needham Buy $52 → $58
Feb-17-17Initiated ROTH Capital Buy $69
Nov-01-16Initiated Aegis Capital Buy
Oct-28-16Reiterated RBC Capital Mkts Outperform $48 → $49
Oct-06-16Reiterated Stifel Buy $50 → $55
Sep-20-16Initiated H.C. Wainwright Buy $66
Sep-15-16Reiterated Stifel Buy $40 → $50
Sep-15-16Reiterated RBC Capital Mkts Outperform $51 → $55
Sep-15-16Reiterated Needham Buy $45 → $52
Sep-15-16Reiterated Cantor Fitzgerald Buy $44 → $50
Sep-14-16Initiated Raymond James Strong Buy
Jun-03-16Resumed Cantor Fitzgerald Buy $44
Nov-04-15Reiterated RBC Capital Mkts Outperform $44 → $50
Sep-17-15Reiterated Stifel Buy $30 → $40
Jan-23-18 04:03PM  Aerie Pharmaceuticals Announces Public Offering of Common Stock Business Wire
Jan-19-18 07:45AM  Market Trends Toward New Normal in Aerie Pharmaceuticals, Martin Midstream Partners, PTC, Powell Industries, BancFirst, and Saul Centers Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jan-18-18 11:36AM  5 'Strong Buy' Stocks From Wall Street's Best-Performing Analysts TheStreet.com
Jan-16-18 06:30AM  Aerie Pharmaceuticals Announces Appointments of Nils Hauptmann as Director of Regulatory Affairs and Pharmacovigilance and Tim Swan as Director of Sales and Transparency Operations Business Wire
Jan-09-18 08:05AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Jan-02-18 08:02AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
06:30AM  Aerie Pharmaceuticals Announces Appointment of Julia Williams as Director of Medical Affairs Business Wire
Dec-26-17 11:50AM  FDA approves Aerie drug sooner than expected sales staff to grow American City Business Journals
Dec-22-17 08:02AM  Pharma Stock Roundup: Aerie's Rhopressa Approved, Label Expansion for BMY, Pfizer Drugs Zacks
Dec-20-17 07:54PM  Is Aerie Pharmaceuticals Inc (NASDAQ:AERI) A Financially Sound Company? Simply Wall St.
03:00AM  Aerie Pharmaceuticals Shows Market Leadership With Jump To 81 RS Rating Investor's Business Daily
Dec-19-17 09:00PM  Aerie Pharmaceuticals Nabs FDA OK for Glaucoma Drug Motley Fool
08:55AM  Aerie (AERI) Gets Early FDA Approval for Lead Drug Rhopressa Zacks
Dec-18-17 06:02PM  Aerie's glaucoma treatment gets early FDA approval Reuters
05:20PM  Aerie's glaucoma treatment gets early FDA approval Reuters
04:47PM  Aerie Pharma eye drug Rhopressa approved by FDA MarketWatch
04:05PM  FDA approves Aerie's glaucoma treatment Reuters
03:52PM  Aerie Pharmaceuticals Announces U.S. FDA Approval of Rhopressa® (netarsudil ophthalmic solution) 0.02% for the Lowering of Elevated Intraocular Pressure in Patients with Open-Angle Glaucoma or Ocular Hypertension Business Wire
Dec-11-17 03:33AM  Why Is Aerie (AERI) Down 5.9% Since the Last Earnings Report? Zacks
03:00AM  Aerie Pharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS Rating Investor's Business Daily
Dec-07-17 08:46AM  Falling Earnings Estimates Signal Weakness Ahead for Aerie Pharmaceuticals (AERI) Zacks
Dec-04-17 06:30AM  Aerie Pharmaceuticals Announces Appointment of Heather Johnson as Regional Sales Director for the Northeast Region Business Wire -5.39%
Dec-01-17 06:30AM  Aerie Pharmaceuticals Announces Appointment of Paul Bae as Vice President of Human Resources Business Wire
Nov-30-17 03:41PM  Aerie Pharmaceuticals, Inc. Fundamental Analysis : November 30, 2017 Capital Cube
Nov-28-17 08:05AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Nov-27-17 06:30AM  Aerie Pharmaceuticals Announces Appointment of Nhi Ong as Director of Analytics Business Wire
Nov-22-17 08:01AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Nov-17-17 06:01PM  Edited Transcript of AERI earnings conference call or presentation 8-Nov-17 10:00pm GMT Thomson Reuters StreetEvents
08:05AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Nov-16-17 04:01PM  Aerie Pharmaceuticals Initiates Netarsudil Ophthalmic Solution Phase 2 Clinical Trial Designed to Meet Requirements of Regulatory Filing in Japan Business Wire
Nov-10-17 08:07AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Nov-09-17 07:55AM  Aerie (AERI) Q3 Loss Wider Than Expected, Pipeline in Focus Zacks
Nov-08-17 04:07PM  Aerie reports 3Q loss Associated Press
04:01PM  Aerie Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update Business Wire
03:10PM  Aerie Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
08:31AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Nov-07-17 08:36AM  Is a Surprise Coming for Aerie (AERI) This Earnings Season? Zacks
07:30AM  Aerie Pharmaceuticals to Present at the Stifel 2017 Healthcare Conference Business Wire
Nov-01-17 05:43PM  TipRanks: Here are 7 top 'strong buy' stocks from the best-performing analysts CNBC
07:30AM  Aerie Pharmaceuticals to Announce Third Quarter 2017 Financial Results and Host Conference Call on Wednesday, November 8, 2017 Business Wire
Oct-30-17 06:39PM  Is Aerie (AERI) Poised for a Beat This Earnings Season? Zacks
06:30AM  Aerie Pharmaceuticals Announces Appointment of John Maltman, Ph.D., as Vice President of Medical Affairs Business Wire
Oct-19-17 03:05PM  Rhopressa Could Be Major Growth Driver for Aerie Pharmaceuticals Market Realist
01:36PM  AERI Expects to Benefit from Demand in Glaucoma Segment Market Realist
11:53AM  What Analysts Recommend for Aerie Pharmaceuticals in October 2017 Market Realist
Oct-17-17 05:59PM  Aerie (AERI) Up on FDA Review Committee Result for Rhopressa Zacks
Oct-13-17 05:20PM  With nod from panel, Aerie inches toward FDA approval American City Business Journals
01:32PM  U.S. FDA panel backs Aerie's glaucoma drug Rhopressa Reuters
01:01PM  Aerie's glaucoma drug Rhopressa wins backing from U.S. FDA panel Reuters
07:33AM  Aerie Pharmaceuticals stock halted for FDA committee review of glaucoma treatment MarketWatch
07:05AM  Aerie Pharmaceuticals Stock Trading Halted Today Business Wire
Oct-12-17 08:30AM  Aerie Pharmaceuticals (AERI) Surges: Stock Moves 16.2% Higher Zacks
Oct-11-17 04:29PM  A Drug Sent This Biotech To A Fresh High But There's A Caveat Investor's Business Daily +16.17%
09:54AM  FDA review says Aerie glaucoma drug effectively lowers eye pressure; shares jump Reuters
08:56AM  Aerie's glaucoma drug effectively lowers eye pressure-FDA review Reuters
07:40AM  Featured Company News - Aerie Expands Research Team; Set to Focus on Drug Delivery Asset Acquired from Envisia ACCESSWIRE
03:00AM  Stocks Showing Rising Market Leadership: Aerie Pharmaceuticals Earns 82 RS Rating Investor's Business Daily
Oct-09-17 06:30AM  Aerie Pharmaceuticals Announces Appointment of New Members of its Research and Development Team Business Wire
Oct-06-17 08:02AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Oct-05-17 06:00AM  Aerie Pharmaceuticals Announces Drug Delivery Asset Acquisition to Further Advance Its Retinal Disease Program Business Wire
03:00AM  Aerie Pharmaceuticals Earns Relative Strength Rating Upgrade; Hits Key Threshold Investor's Business Daily
Oct-03-17 03:00AM  Aerie Pharmaceuticals Sees IBD RS Rating Climb To 73 Investor's Business Daily
Oct-02-17 06:30AM  Aerie Pharmaceuticals Announces Appointment of Ann Keevans as Director of Human Resources - Europe Business Wire
Sep-29-17 06:30AM  Aerie Pharmaceuticals Announces Appointment of New Members of its Commercialization Team Business Wire
Sep-28-17 08:03AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Sep-27-17 08:03AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Sep-26-17 08:02AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Sep-25-17 06:30AM  Aerie Pharmaceuticals Announces Appointment of Sheila Elliott, PharmD, as Western Regional Director of Medical Science Liaisons Business Wire
Sep-21-17 08:02AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
07:20AM  Corporate News Blog - Aerie Pharma Appoints Tori Arens as VP of Drug Product Manufacturing and Eric Carlson as VP of R&D ACCESSWIRE
Sep-20-17 04:14PM  Aerie Tumbles Ahead Of FDA Panel Review Of Glaucoma Drug Investor's Business Daily -8.87%
04:01PM  Aerie Pharmaceuticals Announces FDA Advisory Committee Meeting for Rhopressa (netarsudil ophthalmic solution) 0.02% Business Wire
10:43AM  Jacobs (JEC) Awarded EPCM Contract by Aerie Pharmaceuticals Zacks
08:02AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Sep-19-17 06:30AM  Aerie Pharmaceuticals Announces Appointment of Tori Arens as Vice President of Drug Product Manufacturing and Eric Carlson, Ph.D. as Vice President of Research and Development Business Wire
Sep-13-17 08:53AM  Are Options Traders Betting on a Big Move in Aerie (AERI) Stock? Zacks
Sep-11-17 10:00AM  Aerie Pharmaceuticals, Inc. (Nasdaq: AERI) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire
05:15AM  Why Is Aerie (AERI) Up 10% Since the Last Earnings Report? Zacks
Sep-07-17 09:41AM  Aerie Initiates Phase III Study for Ophthalmic Drug Roclatan Zacks
08:03AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Sep-06-17 07:30AM  Aerie Pharmaceuticals to Present at Two Investor Conferences in September Business Wire
06:30AM  Aerie Pharmaceuticals Initiates Mercury 3 Clinical Trial of RoclatanTM (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005% Business Wire
Sep-01-17 08:02AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Aug-31-17 08:07AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Aug-28-17 06:30AM  Aerie Pharmaceuticals Announces Appointment of Deanne Melloy as Vice President of Marketing and Norbert Lowe as Regional Sales Director Business Wire
Aug-25-17 10:23AM  Ultragenyx Files BLA to FDA for Hypophosphatemia Candidate Zacks
Aug-23-17 04:06PM  Ultragenyx (RARE) Posts Disappointing Phase III Ace-ER Data Zacks
Aug-22-17 08:02AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Aug-17-17 08:04AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Aug-16-17 08:03AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Aug-14-17 08:04AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
06:30AM  Aerie Pharmaceuticals Announces Appointment of Isabel Moredo, PharmD, as Eastern Regional Director of Medical Science Liaisons Business Wire
Aug-12-17 08:15PM  Edited Transcript of AERI earnings conference call or presentation 1-Aug-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-11-17 08:02AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Aug-10-17 04:38PM  Aerie expanding RTP space as it looks to commercialization American City Business Journals
08:03AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Aug-09-17 08:02AM  See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. Markit
Aug-08-17 04:01PM  Aerie Pharmaceuticals Comments on Notification from Contract Manufacturer Business Wire -7.93%
Aug-07-17 08:20AM  Spectrum Pharmaceuticals (SPPI) Looks Good: Stock Jumps 22.2% Zacks
Aug-02-17 10:10AM  Aerie (AERI) Reports Narrower-Than-Expected Loss in Q2 Zacks
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases. Its lead product candidate includes Rhopressa, a once-daily eye drop for the reduction of intraocular pressure (IOP) in patients with glaucoma or ocular hypertension. The company is also developing Roclatan, a once-daily eye drop to reduce IOP that is in Phase III registration trials to treat patients with open-angle glaucoma and ocular hypertension. Aerie Pharmaceuticals, Inc. has a collaborative research and development agreement with Royal DSM NV. Aerie Pharmaceuticals, Inc. was founded in 2005 and is based in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Foresite Capital Management II10% OwnerMay 26Sale55.9520,0001,119,0001,672,714May 31 07:12 PM
Cagle Gerald D.DirectorMay 09Buy39.901,00039,90012,900May 17 04:05 PM
Cagle Gerald D.DirectorApr 19Buy41.702,00083,40011,900Apr 20 04:55 PM
DUYK GEOFFREY MDirectorFeb 15Sale46.8120,796973,4383,400Feb 16 04:03 PM
DUYK GEOFFREY MDirectorFeb 14Option Exercise13.3858,167778,13246,870Feb 16 04:03 PM
DUYK GEOFFREY MDirectorFeb 14Sale46.4620,795966,05924,196Feb 16 04:03 PM